Varian Medical Systems, Inc. (VAR) SVP Sells $93,575.09 in Stock
Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo sold 863 shares of Varian Medical Systems stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $108.43, for a total value of $93,575.09. Following the transaction, the senior vice president now owns 28,224 shares of the company’s stock, valued at approximately $3,060,328.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of Varian Medical Systems, Inc. (NYSE:VAR) traded up $1.24 during midday trading on Wednesday, hitting $109.32. The stock had a trading volume of 822,478 shares, compared to its average volume of 783,936. Varian Medical Systems, Inc. has a 12-month low of $76.94 and a 12-month high of $114.09. The stock has a market cap of $10,020.00, a P/E ratio of 39.61, a PEG ratio of 3.30 and a beta of 0.68.
Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The business had revenue of $739.00 million during the quarter, compared to analysts’ expectations of $741.69 million. During the same quarter in the previous year, the firm earned $1.03 EPS. Varian Medical Systems’s quarterly revenue was down 1.1% on a year-over-year basis. research analysts anticipate that Varian Medical Systems, Inc. will post 4.11 earnings per share for the current year.
A number of research firms have issued reports on VAR. Evercore ISI began coverage on Varian Medical Systems in a research note on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price target for the company. Royal Bank of Canada set a $105.00 price target on Varian Medical Systems and gave the company a “hold” rating in a research note on Thursday, November 30th. Citigroup lifted their price target on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, October 29th. Finally, Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, October 27th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the company. Varian Medical Systems presently has a consensus rating of “Hold” and a consensus price target of $100.44.
WARNING: “Varian Medical Systems, Inc. (VAR) SVP Sells $93,575.09 in Stock” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/17/varian-medical-systems-inc-var-svp-sells-93575-09-in-stock.html.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.